AUTS2 Syndrome: Molecular Mechanisms and Model Systems
Overview
Authors
Affiliations
AUTS2 syndrome is a genetic disorder that causes intellectual disability, microcephaly, and other phenotypes. Syndrome severity is worse when mutations involve 3' regions (exons 9-19) of the gene. Human AUTS2 protein has two major isoforms, full-length (1259 aa) and C-terminal (711 aa), the latter produced from an alternative transcription start site in exon 9. Structurally, AUTS2 contains the putative "AUTS2 domain" (∼200 aa) conserved among AUTS2 and its ohnologs, fibrosin, and fibrosin-like-1. Also, AUTS2 contains extensive low-complexity sequences and intrinsically disordered regions, features typical of RNA-binding proteins. During development, is expressed by specific progenitor cell and neuron types, including pyramidal neurons and Purkinje cells. AUTS2 localizes mainly in cell nuclei, where it regulates transcription and RNA metabolism. Some studies have detected AUTS2 in neurites, where it may regulate cytoskeletal dynamics. Neurodevelopmental functions of AUTS2 have been studied in diverse model systems. In zebrafish, morphants displayed microcephaly. In mice, excision of different exons (7, 8, or 15) caused distinct phenotypes, variously including neonatal breathing abnormalities, cerebellar hypoplasia, dentate gyrus hypoplasia, EEG abnormalities, and behavioral changes. In mouse embryonic stem cells, AUTS2 could promote or delay neuronal differentiation. Cerebral organoids, derived from an AUTS2 syndrome patient containing a pathogenic missense variant in exon 9, exhibited neocortical growth defects. Emerging technologies for analysis of human cerebral organoids will be increasingly useful for understanding mechanisms underlying AUTS2 syndrome. Questions for future research include whether AUTS2 binds RNA directly, how AUTS2 regulates neurogenesis, and how AUTS2 modulates neural circuit formation.
Lepagnol-Bestel A, Loe-Mie Y, Bensaid M, Simonneau M Genes Dis. 2025; 12(3):101440.
PMID: 39897131 PMC: 11786819. DOI: 10.1016/j.gendis.2024.101440.
Shimaoka K, Hori K, Miyashita S, Inoue Y, Tabe N, Sakamoto A EMBO J. 2025; 44(5):1354-1378.
PMID: 39815005 PMC: 11876313. DOI: 10.1038/s44318-024-00343-7.
Duan W, Zhou T, Huang X, He D, Hu M BMC Med Genomics. 2025; 18(1):4.
PMID: 39773702 PMC: 11705921. DOI: 10.1186/s12920-024-02078-0.
Single-Nucleus Atlas of Cell-Type Specific Genetic Regulation in the Human Brain.
Zeng B, Yang H, N M P, Venkatesh S, Mathur D, Auluck P Res Sq. 2024; .
PMID: 39711543 PMC: 11661307. DOI: 10.21203/rs.3.rs-5368620/v1.
Functional characteristics and computational model of abundant hyperactive loci in the human genome.
Hudaiberdiev S, Ovcharenko I Elife. 2024; 13.
PMID: 39535534 PMC: 11560132. DOI: 10.7554/eLife.95170.